[SYRE] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Sep-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -19.72%
YoY- -81.03%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -21,418 -18,728 -21,495 -21,573 -18,019 -17,167 -14,898 27.40%
Tax 0 0 0 0 0 0 0 -
NP -21,418 -18,728 -21,495 -21,573 -18,019 -17,167 -14,898 27.40%
Tax Rate - - - - - - - -
Total Cost 21,418 18,728 21,495 21,573 18,019 17,167 14,898 27.40%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -10.11 -14.15 0.00 -16.40 -13.72 -14.79 0.00 -
EPS Diluted -10.11 -14.15 0.00 -16.40 -13.72 -14.79 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.